查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球心臟幫浦設備市場 2023-2030
市場調查報告書
商品編碼
1380454

全球心臟幫浦設備市場 2023-2030

Global Heart Pump Device Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 205 Pages | 商品交期: 2-3個工作天內

價格

全球心臟幫浦設備市場預計在預測期內（2023-2030年）CAGR為21.4%。患有心血管疾病（CVD）的人數不斷增加、心臟衰竭發病率上升等關鍵因素正在推動市場成長。據世界衛生組織稱，心血管疾病 (CVD) 是全球主要死亡原因，每年估計奪走 1,790 萬人的生命。此外，心臟泵產品研發投資的增加預計將透過促進這些設備的接受度和使用率的提高來推動市場成長。 2022 年 10 月，開發全人工心臟的臨床前醫療器材公司 BiVACOR (R) 透過其醫學研究未來基金 (MRFF) 和定向轉化研究加速器 (TTRA) 計畫獲得了澳洲政府提供的 75 萬美元資助。

細分市場前景

全球心臟幫浦設備市場按類型和最終用戶進行細分。根據類型，市場分為植入式心臟幫浦設備和體外心臟幫浦設備。根據產品，市場細分為心室輔助裝置、主動脈內球囊幫浦（IABP）和體外膜氧合（ECMO）。此外，根據最終用戶，市場分為醫院和心臟中心。在最終用戶中，由於設備齊全、交通便利、信任和可靠，預計醫院細分市場將佔據相當大的市場佔有率。

預計心室輔助設備細分市場將在全球心泵設備市場中佔據相當大的佔有率

其中，心室輔助裝置細分市場預計將在全球心泵裝置市場中佔據相當大的佔有率。節段性成長歸因於暫時性心臟衰竭發生率的上升，在等待捐贈心臟可用時暫時使用 LVAD，以及由於年齡或其他因素而無法進行心臟移植的人擴大使用 LVAD。此外，FDA 核准的產品數量不斷增加也促進了 LVAD 的採用。 2019 年10 月，醫療技術先驅美敦力公司(Medtronic plc) 的用於晚期心臟衰竭患者的美敦力完全植入式LVAD 獲得了美國食品和藥物管理局(FDA) 的突破性設備認定，目前該產品正在開發中。

區域展望

全球心臟幫浦設備市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，亞太地區預計將在全球市場中佔據顯著佔有率，因為心臟衰竭盛行率的增加，以及新興經濟體可支配收入增加導致的生活方式的改變，正在推動亞太地區的心臟幫浦設備市場。

北美地區全球心泵設備市場預計將以顯著的複合CAGR成長

在所有地區中，北美地區預計在預測期內將以相當大的CAGR成長。推動北美市場的主要因素包括由於心血管疾病（CVD）和心臟衰竭而導致的心臟移植需求的增加。根據《2022 年心臟病和中風統計》，2019 年，CVD 被列為根本死因，美國有 874,613 人死亡。 2019年，美國大約每40秒就有一人罹患心肌梗塞，平均每3分30秒就有一人死於中風。然而，由於無法提供足夠的心臟用於移植以滿足現有需求，導致了短缺危機。此外，根據美國衛生資源與服務管理局 (HRSA) 的數據，截至 2023 年 9 月，心臟移植等候名單上有 3,292 名候選人。因此，心臟泵設備預計在未來幾年將出現巨大的利用率和需求。

市場參與者展望

服務全球心臟幫浦設備市場的主要公司包括： Abbott Laboratories、Berlin Heart GmbH、Boston Scientific Corp.、Medtronic plc、Terumo Corp. 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2022 年 11 月，強生公司與突破性心、肺和腎臟支持技術的全球供應商 Abiomed 簽訂了一項最終協議，根據該協議，強生公司透過要約收購收購了 Abiomed 的所有已發行股票，每股預付款380.0 美元現金，相當於企業價值約166 億美元（其中包括收購的現金）。此次收購增加了心臟恢復解決方案，以補充其 Biosense Webster 電生理學業務，使該公司能夠在高成長市場中擴張。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球心臟泵設備市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Berlin Heart GmbH
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Boston Scientific Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Medtronic plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按類型分類的全球心臟幫浦設備市場
    • 植入式心臟幫浦裝置
    • 體外心臟幫浦裝置
  • 按產品分類的全球心泵設備市場
    • 心室輔助裝置
      • 左心室輔助裝置 (LVAD)
      • 右心室輔助裝置 (RVAD)
      • 雙心室輔助裝置 (BiVAD)
      • 經皮心室輔助裝置 (PVAD)
    • 全人工心臟 (TAH)
    • 體外膜氧合（ECMO）
  • 按最終用途分類的全球心泵設備市場
    • 醫院
    • 心臟中心

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • BiVACOR Inc.
  • CardiacAssist, Inc. (TandemLife)
  • CARMAT
  • CorWave SA
  • Evaheart, Inc.
  • Fresenius SE & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • Johnson & Johnson Services, Inc.
  • Leviticus-Cardio Ltd.
  • LivaNova PLC
  • ReliantHeart Inc.
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Terumo Corp.
Product Code: OMR2027761

Title: Global Heart Pump Device Market Size, Share & Trends Analysis Report by Type (Implanted Heart Pump Devices and Extracorporeal Heart Pump Devices), by Product (Ventricular Assist Devices, Total Artificial Hearts (TAHs), and Extracorporeal Membrane Oxygenation (ECMO)), and by End-User (Hospital and Cardiac Centers)Forecast Period (2023-2030).

The global heart pump device market is anticipated to grow at a CAGR of 21.4% during the Forecast Period (2023-2030). Pivotal factors including the increasing number of individuals suffering from cardiovascular diseases (CVD), rising incidences of heart failure are driving the market growth. According to the World Health Organization, Cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year. Further, the increasing investment in R&D for heart pump products is projected to drive market growth by promoting increased acceptance and usage of these devices. In October 2022, BiVACOR®, a preclinical medical device company developing a Total Artificial Heart, received a $750k grant from the Australian Government through its medical research future fund (MRFF) and targeted translation research accelerator (TTRA) program.

Segmental Outlook

The global heart pump device market is segmented on the type, and end user. Based on the type, the market is sub-segmented into implanted heart pump devices and extracorporeal heart pump devices. Based on the product, the market is sub-segmented into ventricular assist devices, intra-aortic balloon pumps (IABPs) and extracorporeal membrane oxygenation (ECMO). Further, on the basis of end user, the market is sub-segmented into hospital and cardiac centers. Among the end user, the hospitals sub-segment is anticipated to hold a considerable share of the market, owing to the well-equipped settings, easily accessible, trust and reliability.

The Ventricular Assist Devices Sub-Segment is Anticipated to Hold a Considerable Share of the Global Heart Pump Device Market

Among the product, the ventricular assist devices sub-segment is expected to hold a considerable share of the global heart pump device market. The segmental growth is attributed to the rising incidences of temporary heart failure, temporarily used of LVAD while waiting for a donor heart to become available, increasing use of LVAD who can't have a heart transplant because of age or other factors. Additionally, the rising number of FDA approvals of the products are also contributing to the increasing adoption for LVAD. In October 2019, Medtronic plc, the pioneer in medical technology, received breakthrough device designation from the US Food and Drug Administration (FDA) for the Medtronic Fully Implantable LVAD for patients with advanced heart failure, currently in development.

Regional Outlook

The global heart pump device market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, Asia pacific is anticipated to hold a prominent share of the market across the globe, owing to the increasing prevalence of heart failure, and the and changes in lifestyles owing to rising disposable income in emerging economies are driving the heart pump device market in the Asia Pacific.

The North America Region is Expected to Grow at a Significant CAGR in the Global Heart Pump Device Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. The major factors driving the North America market includes the increasing demand for heart transplantation owing to the Cardiovascular diseases' (CVDs) and heart failure. According to the Heart Disease and Stroke Statistics 2022, in 2019, CVD listed as the underlying cause of death, accounted for 874,613 mortalities in the US. In 2019, approximately every 40 seconds, one person in the US suffered with a myocardial infarction and on average people died of stroke every 3 minutes 30 seconds in the country. Though, the unavailability of adequate hearts for transplantation to meet the existing demand resulted in shortage crisis. Furtermore, according to the Health Resources and Services Administration (HRSA) US, as of September 2023, there were 3,292 candidates on heart transplant waiting list. Thus, the heart pump device is expected to witness a huge utilization and demand in the coming years.

Market Players Outlook

The major companies serving the global heart pump device market include: Abbott Laboratories, Berlin Heart GmbH, Boston Scientific Corp., Medtronic plc, Terumo Corp., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2022, Johnson & Johnson Inc. and Abiomed, a global provider in breakthrough heart, lung, and kidney support technologies, entered into a definitive agreement under which Johnson & Johnson acquired through a tender offer all outstanding shares of Abiomed, for an upfront payment of $380.0 per share in cash, corresponding to an enterprise value of approximately $16.6 billion which includes cash acquired. The acquisition added heart recovery solutions to complement its Biosense Webster electrophysiology business, allowing the company expand in high-growth markets.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global heart pump device market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight and Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Berlin Heart GmbH
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Boston Scientific Corp.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Medtronic plc
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Heart Pump Device Market by Type
    • 4.1.1. Implanted Heart Pump Devices
    • 4.1.2. Extracorporeal Heart Pump Devices
  • 4.2. Global Heart Pump Device Market by Product
    • 4.2.1. Ventricular Assist Devices
      • 4.2.1.1. Left Ventricular Assist Devices (LVAD)
      • 4.2.1.2. Right Ventricular Assist Devices (RVAD)
      • 4.2.1.3. Bi-Ventricular Assist Devices (BiVAD)
      • 4.2.1.4. Percutaneous Ventricular Assist Devices (PVAD)
    • 4.2.2. Total Artificial Hearts (TAHs)
    • 4.2.3. Extracorporeal Membrane Oxygenation (ECMO)
  • 4.3. Global Heart Pump Device Market by End-Use
    • 4.3.1. Hospital
    • 4.3.2. Cardiac Centers

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. BiVACOR Inc.
  • 6.2. CardiacAssist, Inc. (TandemLife)
  • 6.3. CARMAT
  • 6.4. CorWave SA
  • 6.5. Evaheart, Inc.
  • 6.6. Fresenius SE & Co. KGaA
  • 6.7. Getinge AB
  • 6.8. Jarvik Heart, Inc.
  • 6.9. Johnson & Johnson Services, Inc.
  • 6.10. Leviticus-Cardio Ltd.
  • 6.11. LivaNova PLC
  • 6.12. ReliantHeart Inc.
  • 6.13. SynCardia Systems, LLC
  • 6.14. Teleflex Incorporated
  • 6.15. Terumo Corp.

LIST OF TABLES

  • 1. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL IMPLANTED HEART PUMP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL EXTRACORPOREAL HEART PUMP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 5. GLOBAL VENTRICULAR ASSIST HEART PUMP DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL TOTAL ARTIFICIAL HEARTS (TAHS) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL INTRA-AORTIC BALLOON HEART PUMPS (IABPS) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) HEART PUMP MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY VENTRICULAR ASSIST DEVICES, 2022-2030 ($ MILLION)
  • 10. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL BI-VENTRICULAR ASSIST DEVICES (BIVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL PERCUTANEOUS VENTRICULAR ASSIST DEVICES (PVAD) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 15. GLOBAL HEART PUMP DEVICE FOR HOSPITAL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 16. GLOBAL HEART PUMP DEVICE FOR CARDIAC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. GLOBAL HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 25. EUROPEAN HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 28. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)
  • 30. REST OF THE WORLD HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD HEART PUMP DEVICE MARKET RESEARCH AND ANALYSIS BY END-USE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL HEART PUMP DEVICE MARKET SHARE BY COMPONENT, 2022 VS 2030 (%)
  • 2. GLOBAL IMPLANTED HEART PUMP DEVICE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL EXTRACORPOREAL HEART PUMP DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL HEART PUMP DEVICE MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 5. GLOBAL VENTRICULAR ASSIST HEART PUMP DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL VENTRICULAR ASSIST HEART PUMP DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL TOTAL ARTIFICIAL HEARTS (TAHS) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL INTRA-AORTIC BALLOON HEART PUMPS (IABPS) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) HEART PUMP MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL HEART PUMP DEVICE MARKET SHARE BY VENTRICULAR ASSIST DEVICES, 2022 VS 2030 (%)
  • 11. GLOBAL LEFT VENTRICULAR ASSIST DEVICES (LVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL RIGHT VENTRICULAR ASSIST DEVICES (RVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL BI-VENTRICULAR ASSIST DEVICES (BIVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL PERCUTANEOUS VENTRICULAR ASSIST DEVICES (PVAD) MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. GLOBAL HEART PUMP DEVICE MARKET SHARE BY END-USE, 2022 VS 2030 (%)
  • 16. GLOBAL HEART PUMP DEVICE FOR HOSPITAL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL HEART PUMP DEVICE FOR CARDIAC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. GLOBAL HEART PUMP DEVICE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 19. US HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. CANADA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. UK HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. FRANCE HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. GERMANY HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. ITALY HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SPAIN HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF EUROPE HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. INDIA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. CHINA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. JAPAN HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. SOUTH KOREA HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF ASIA-PACIFIC HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD HEART PUMP DEVICE MARKET SIZE, 2022-2030 ($ MILLION)